Solid Biosciences

Solid Biosciences

Advance the development of its novel gene therapy platform.

Launch date
Employees
Market cap
$298m
Enterprise valuation
$133m (Public information from Sep 2024)
Boston Massachusetts (HQ)
Authorizing premium user...